APA (7th ed.) Citation

Ringelstein, M., Ayzenberg, I., Lindenblatt, G., Fischer, K., Gahlen, A., Novi, G., . . . Aktaş, O. (2022). Interleukin-6 receptor blockade in treatment-refractory MOG-IgG-associated disease and neuromyelitis optica spectrum disorders. Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology, 9(1), . https://doi.org/10.1212/NXI.0000000000001100

Chicago Style (17th ed.) Citation

Ringelstein, Marius, et al. "Interleukin-6 Receptor Blockade in Treatment-refractory MOG-IgG-associated Disease and Neuromyelitis Optica Spectrum Disorders." Neurology: Neuroimmunology & Neuroinflammation ; Official Journal of the American Academy of Neurology 9, no. 1 (2022). https://doi.org/10.1212/NXI.0000000000001100.

MLA (9th ed.) Citation

Ringelstein, Marius, et al. "Interleukin-6 Receptor Blockade in Treatment-refractory MOG-IgG-associated Disease and Neuromyelitis Optica Spectrum Disorders." Neurology: Neuroimmunology & Neuroinflammation ; Official Journal of the American Academy of Neurology, vol. 9, no. 1, 2022, https://doi.org/10.1212/NXI.0000000000001100.